Anti-integrin alpha v beta 8 antibodies and procedures for use.
CL202600807A1Pending Publication Date: 2026-07-03GENENTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600807
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-03-29
- Filing Date
- 2026-03-18
- Publication Date
- 2026-07-03
Abstract
This document provides anti-alpha 5 beta 8 antibodies or antigen-binding portions thereof, and procedures for their manufacture and use. It also provides procedures for treating cancer with an anti-alpha 5 beta 8 antibody and a PD-1 axis antagonist.
Need to check novelty before this filing date? Find Prior Art